000			02174 a2200565 4500
005			20250517233323.0
264		0	_c20190225
008			201902s 0 0 eng d
022			_a1873-2399
024	7		_a10.1016/j.exphem.2018.08.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aBarve, Aditya
245	0	0	_aComparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response. _h[electronic resource]
260			_bExperimental hematology _c11 2018
300			_a18-31 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aChild
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDNA-Activated Protein Kinase _xdeficiency
650	0	4	_aDNA-Binding Proteins _xdeficiency
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aGraft Survival
650	0	4	_aGranulocyte-Macrophage Colony-Stimulating Factor _xgenetics
650	0	4	_aHematopoiesis
650	0	4	_aHematopoietic Stem Cell Transplantation _xmethods
650	0	4	_aHumans
650	0	4	_aInterleukin Receptor Common gamma Subunit _xdeficiency
650	0	4	_aInterleukin-3 _xgenetics
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aMice
650	0	4	_aMice, Inbred Strains _xgenetics
650	0	4	_aMice, Transgenic _xgenetics
650	0	4	_aNeoplasm Transplantation _xmethods
650	0	4	_aNuclear Proteins _xdeficiency
650	0	4	_aRemission Induction
650	0	4	_aSpecies Specificity
650	0	4	_aStem Cell Factor _xgenetics
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aCasson, Lavona
700	1		_aKrem, Maxwell
700	1		_aWunderlich, Mark
700	1		_aMulloy, James C
700	1		_aBeverly, Levi J
773	0		_tExperimental hematology _gvol. 67 _gp. 18-31
856	4	0	_uhttps://doi.org/10.1016/j.exphem.2018.08.004 _zAvailable from publisher's website
999			_c28747503 _d28747503